318 related articles for article (PubMed ID: 11412096)
1. Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?
Kaplan D; Ordentlich A; Barak D; Ariel N; Kronman C; Velan B; Shafferman A
Biochemistry; 2001 Jun; 40(25):7433-45. PubMed ID: 11412096
[TBL] [Abstract][Full Text] [Related]
2. The aromatic "trapping" of the catalytic histidine is essential for efficient catalysis in acetylcholinesterase.
Barak D; Kaplan D; Ordentlich A; Ariel N; Velan B; Shafferman A
Biochemistry; 2002 Jul; 41(26):8245-52. PubMed ID: 12081473
[TBL] [Abstract][Full Text] [Related]
3. Functional requirements for the optimal catalytic configuration of the AChE active center.
Shafferman A; Barak D; Kaplan D; Ordentlich A; Kronman C; Velan B
Chem Biol Interact; 2005 Dec; 157-158():123-31. PubMed ID: 16256968
[TBL] [Abstract][Full Text] [Related]
4. The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.
Ariel N; Ordentlich A; Barak D; Bino T; Velan B; Shafferman A
Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):95-102. PubMed ID: 9742217
[TBL] [Abstract][Full Text] [Related]
5. Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.
Harel M; Sussman JL; Krejci E; Bon S; Chanal P; Massoulié J; Silman I
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10827-31. PubMed ID: 1438284
[TBL] [Abstract][Full Text] [Related]
6. Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers.
Ordentlich A; Barak D; Kronman C; Benschop HP; De Jong LP; Ariel N; Barak R; Segall Y; Velan B; Shafferman A
Biochemistry; 1999 Mar; 38(10):3055-66. PubMed ID: 10074358
[TBL] [Abstract][Full Text] [Related]
7. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
8. Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
Komloova M; Musilek K; Horova A; Holas O; Dohnal V; Gunn-Moore F; Kuca K
Bioorg Med Chem Lett; 2011 Apr; 21(8):2505-9. PubMed ID: 21397501
[TBL] [Abstract][Full Text] [Related]
9. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
10. Functional characteristics of the oxyanion hole in human acetylcholinesterase.
Ordentlich A; Barak D; Kronman C; Ariel N; Segall Y; Velan B; Shafferman A
J Biol Chem; 1998 Jul; 273(31):19509-17. PubMed ID: 9677373
[TBL] [Abstract][Full Text] [Related]
11. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket.
Ordentlich A; Barak D; Kronman C; Flashner Y; Leitner M; Segall Y; Ariel N; Cohen S; Velan B; Shafferman A
J Biol Chem; 1993 Aug; 268(23):17083-95. PubMed ID: 8349597
[TBL] [Abstract][Full Text] [Related]
12. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
13. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
[TBL] [Abstract][Full Text] [Related]
14. Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.
Komloova M; Horova A; Hrabinova M; Jun D; Dolezal M; Vinsova J; Kuca K; Musilek K
Bioorg Med Chem Lett; 2013 Dec; 23(24):6663-6. PubMed ID: 24220173
[TBL] [Abstract][Full Text] [Related]
15. Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis.
Loewenstein-Lichtenstein Y; Glick D; Gluzman N; Sternfeld M; Zakut H; Soreq H
Mol Pharmacol; 1996 Dec; 50(6):1423-31. PubMed ID: 8967962
[TBL] [Abstract][Full Text] [Related]
16. Is aromaticity essential for trapping the catalytic histidine 447 in human acetylcholinesterase?
Kaplan D; Barak D; Ordentlich A; Kronman C; Velan B; Shafferman A
Biochemistry; 2004 Mar; 43(11):3129-36. PubMed ID: 15023064
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core.
Barak D; Kronman C; Ordentlich A; Ariel N; Bromberg A; Marcus D; Lazar A; Velan B; Shafferman A
J Biol Chem; 1994 Mar; 269(9):6296-305. PubMed ID: 8119978
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
19. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of Torpedo californica acetylcholinesterase by reversible inhibitors.
Weiner L; Shnyrov VL; Konstantinovskii L; Roth E; Ashani Y; Silman I
Biochemistry; 2009 Jan; 48(3):563-74. PubMed ID: 19115961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]